BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6953260)

  • 1. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
    Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
    Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental and clinical evaluation of cefotetan in pediatrics].
    Toyonaga Y; Kurosu Y; Sugita M; Kita A; Yoshino N; Kouda N; Kumagai K; Horiuchi K; Hori M; Takahashi T
    Jpn J Antibiot; 1983 Jun; 36(6):1243-60. PubMed ID: 6581330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
    Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental and clinical evaluation of cefotetan in pediatrics].
    Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Takagi M
    Jpn J Antibiot; 1983 Jun; 36(6):1301-12. PubMed ID: 6581335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical evaluation of cefotetan in pediatrics].
    Iwata S; Iwasaki Y; Kanemitsu T; Tojo M; Jozaki K; Akita H; Kojima Y; Wakabayashi R; Sunakawa K; Osano M
    Jpn J Antibiot; 1983 Jun; 36(6):1204-18. PubMed ID: 6581327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of cefotetan in pediatrics].
    Meguro H; Ozawa S; Togo T; Kim B; Arimasu O; Yonezawa H; Fujii R
    Jpn J Antibiot; 1983 Jun; 36(6):1262-70. PubMed ID: 6581331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
    Tsuji A; Goto S; Sato K; Tomizawa M; Hasebe S; Takagi T; Yatagai S; Kanno H; Ozaki K; Yakata M
    Jpn J Antibiot; 1985 Aug; 38(8):2171-84. PubMed ID: 3908734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical evaluation of a new cephamycin antibiotic, cefotetan, in pediatrics].
    Nakazawa S; Sato H; Niino K; Suzuki H; Nakazawa S; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1983 Jun; 36(6):1219-32. PubMed ID: 6581328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoxitin and cephamycins: microbiological studies.
    Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
    Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
    Morel C; Vergnaud M; Langeard MM; Dupuy L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
    Wallick H; Hendlin D
    Antimicrob Agents Chemother; 1974 Jan; 5(1):25-32. PubMed ID: 4840447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antibacterial activity of cefotetan.
    Grassi GG; Alesina R; Ferrara A; Peona V
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():45-58. PubMed ID: 6573325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.